Logo image of ATRA

ATARA BIOTHERAPEUTICS INC (ATRA) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:ATRA - US0465132068 - Common Stock

12.32 USD
+0.1 (+0.82%)
Last: 12/3/2025, 1:40:17 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to ATRA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 16.83. This target is 36.61% above the current price.
ATRA was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ATRA.
In the previous month the buy percentage consensus was at a similar level.
ATRA was analyzed by 9 analysts. More opinions would make the average more meaningful.
ATRA Historical Analyst RatingsATRA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -107 -97 -87 -77 -67 -57 -47 -37 -27 -17 -7 5 10 15

Price Target & Forecast

Price Low Median Mean High 12.3216.1616.8316.8317.85 - 31.17% 36.61% 36.61% 44.89%
ATRA Current Analyst RatingATRA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-03-11 Canaccord Genuity Maintains Buy -> Buy
2025-01-28 HC Wainwright & Co. Reiterate Neutral -> Neutral
2025-01-22 HC Wainwright & Co. Reiterate Neutral -> Neutral
2025-01-17 Canaccord Genuity Maintains Buy -> Buy
2024-12-20 Rodman & Renshaw Initiate Buy
2024-11-13 Canaccord Genuity Maintains Buy -> Buy
2024-08-21 HC Wainwright & Co. Reiterate Neutral
2024-08-16 Mizuho Upgrade Neutral -> Outperform
2024-08-13 Canaccord Genuity Maintains Buy -> Buy
2024-07-17 Goldman Sachs Maintains Sell -> Sell
2024-05-22 HC Wainwright & Co. Reiterate Neutral
2024-04-01 Stifel Maintains Hold -> Hold
2023-11-10 Goldman Sachs Maintains Sell -> Sell
2023-11-09 Mizuho Downgrade Buy -> Neutral
2023-11-09 Evercore ISI Group Downgrade Outperform -> In-Line
2023-11-09 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-09-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-21 Citigroup Maintains Sell -> Sell
2023-08-09 EF Hutton Reiterate Buy -> Buy
2023-06-14 HC Wainwright & Co. Maintains Buy -> Buy
2023-05-09 Canaccord Genuity Maintains Buy
2023-02-09 EF Hutton Reiterate Buy
2023-02-09 HC Wainwright & Co. Maintains Buy
2023-02-07 Mizuho Reiterate Buy
2023-01-05 EF Hutton Initiate Buy
2022-08-16 Mizuho Maintains Buy
2022-08-09 Goldman Sachs Maintains Sell
2022-07-20 Citigroup Downgrade Neutral -> Sell
2022-07-13 Stifel Downgrade Buy -> Hold
2022-07-13 JP Morgan Downgrade Overweight -> Neutral

ATARA BIOTHERAPEUTICS INC / ATRA FAQ

What do analysts expect the price target to be for ATARA BIOTHERAPEUTICS INC (ATRA)?

9 analysts have analysed ATRA and the average price target is 16.83 USD. This implies a price increase of 36.61% is expected in the next year compared to the current price of 12.32.


Can you provide the consensus rating for ATARA BIOTHERAPEUTICS INC stock?

The consensus rating for ATARA BIOTHERAPEUTICS INC (ATRA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.